Posts Categorized: MS News

Source UAB News: Results from a clinical trial of more than 250 participants with progressive multiple sclerosis revealed that ibudilast was better than a placebo in slowing down brain shrinkage. The study also showed that the main side effects of ibudilast were gastrointestinal and headaches. The study was supported by the National Institute of Neurological Disorders and… Read more »

Source MS Society: Ocrelizumab should be available on the NHS for everyone with primary progressive MS who could benefit. We call on NHS England, the National Institute of Health and Care Excellence (NICE) and Roche to work together to secure a deal to make that happen. Raise your voice and help the MS Society tell NICE and… Read more »

Do you or your partner have MS? Would you like to help design an app to help people with MS manage fatigue? The University of Sheffield has asked for volunteers to help with their research study. They asked a group of people with MS, and a group of healthcare professionals, about what they thought the… Read more »

Source Science Daily: Cleveland Clinic researchers have discovered a new subtype of multiple sclerosis (MS), providing a better understanding of the individualized nature of the disease. MS has long been characterized as a disease of the brain’s white matter, where immune cells destroy myelin — the fatty protective covering on nerve cells. The destruction of myelin… Read more »

Source MS Research Australia: Brain disease genes linked to primary progressive MS risk.  Despite many genes being found that contribute to the risk of developing MS, so far research has not identified genes that are specific for the risk of developing the primary progressive form of MS. Now, a new international study has shown that rare… Read more »

Source Novartis: SymTrac™ is a free app available on iPhone and Android that helps people with Multiple Sclerosis (MS) track general wellbeing and symptoms over time. The data recorded can be viewed in easy-to-read charts and shared with MS specialist teams to enhance consultation time and support decision making. SymTrac™ is the first MS app to… Read more »

Source MS Society: Government review says doctors should be able to prescribe cannabis for medicinal use. (Note: What medical professionals usually mean by ‘medicinal cannabis’ or ‘medical cannabis’ is cannabis products licensed as medical treatments. So for MS, that means Sativex, which is specifically licensed to treat muscle spasms and stiffness in MS. Journalists or other… Read more »

Source Mail Online: Could vaccine for a common virus stop multiple sclerosis? Doctors think they have discovered the cause of disease. (Note: The researchers’ explanation is currently just a theory but they plan to carry out further research.) A vaccine for avoiding multiple sclerosis has moved a step closer, as doctors believe they have discovered the cause… Read more »

If you are disabled, driving can seem a daunting prospect. The Queen Elizabeth Foundation are specialists in all aspects of driving for disabled people, with expert assessors and instructors backed by specialist technology. They have a wide variety of specially adapted dual-controlled cars fitted with hand controls and left foot accelerators, swivel seat and hi-tech… Read more »

Attention, concentration and fatigue in long-term conditions study:  Participants who attend the testing session in London will be paid £20.00 Do you have a long-term condition such as multiple sclerosis or cancer? People with these conditions often report high levels of fatigue and difficulties with attention and concentration. This research is interested in understanding these issues… Read more »